FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for Xanax XR (alprazolam) submitted by Viatris Specialty LLC. The action updates the labeling under NDA 021434.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Panic Disorder

Drugs mentioned

• XANAX XR (alprazolam)

Snippet

SUPPL AP for XANAX XR (ALPRAZOLAM)